|
1
|
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease.
|
Gastroenterology
|
2004
|
5.94
|
|
2
|
Long-term evolution of disease behavior of Crohn's disease.
|
Inflamm Bowel Dis
|
2002
|
4.13
|
|
3
|
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis.
|
J Crohns Colitis
|
2010
|
3.97
|
|
4
|
Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.
|
Gastroenterology
|
2011
|
3.08
|
|
5
|
Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease.
|
Gastroenterology
|
2012
|
2.95
|
|
6
|
Cancers complicating inflammatory bowel disease.
|
N Engl J Med
|
2015
|
2.33
|
|
7
|
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.
|
Gut
|
2012
|
2.17
|
|
8
|
Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy.
|
Gut
|
2010
|
1.98
|
|
9
|
Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.
|
Gut
|
2010
|
1.87
|
|
10
|
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.
|
J Crohns Colitis
|
2012
|
1.71
|
|
11
|
Risk factors associated with small bowel adenocarcinoma in Crohn's disease: a case-control study.
|
Am J Gastroenterol
|
2008
|
1.52
|
|
12
|
Factors affecting outcomes in Crohn's disease over 15 years.
|
Gut
|
2012
|
1.52
|
|
13
|
Long-term outcome of patients with Crohn's disease who respond to azathioprine.
|
Clin Gastroenterol Hepatol
|
2012
|
1.52
|
|
14
|
Saccharomyces boulardii does not prevent relapse of Crohn's disease.
|
Clin Gastroenterol Hepatol
|
2013
|
1.50
|
|
15
|
Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis.
|
Am J Gastroenterol
|
2007
|
1.46
|
|
16
|
Sera from patients with Crohn's disease break bacterial lipopolysaccharide tolerance of human intestinal epithelial cells via MD-2 activity.
|
Innate Immun
|
2010
|
1.43
|
|
17
|
Crohn's disease over 20 years after diagnosis in a referral population.
|
Gastroenterol Clin Biol
|
2004
|
1.41
|
|
18
|
Natural history of Crohn's disease: comparison between childhood- and adult-onset disease.
|
Inflamm Bowel Dis
|
2010
|
1.31
|
|
19
|
Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum.
|
Joint Bone Spine
|
2004
|
1.10
|
|
20
|
Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability.
|
J Clin Oncol
|
2007
|
1.08
|
|
21
|
Effects of light smoking consumption on the clinical course of Crohn's disease.
|
Inflamm Bowel Dis
|
2009
|
1.03
|
|
22
|
Small bowel adenocarcinoma in patients with Crohn's disease compared with small bowel adenocarcinoma de novo.
|
Inflamm Bowel Dis
|
2005
|
1.03
|
|
23
|
Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process.
|
Am J Gastroenterol
|
2012
|
0.97
|
|
24
|
Incidence, presentation, and prognosis of small bowel adenocarcinoma in patients with small bowel Crohn's disease: a prospective observational study.
|
Inflamm Bowel Dis
|
2013
|
0.96
|
|
25
|
Gender differences in the response of colitis to smoking.
|
Clin Gastroenterol Hepatol
|
2004
|
0.96
|
|
26
|
Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis.
|
World J Gastroenterol
|
2008
|
0.96
|
|
27
|
Cancer risk in immune-mediated inflammatory diseases (IMID).
|
Mol Cancer
|
2013
|
0.95
|
|
28
|
Current smoking differentially affects blood mononuclear cells from patients with Crohn's disease and ulcerative colitis: relevance to its adverse role in the disease.
|
Inflamm Bowel Dis
|
2011
|
0.95
|
|
29
|
Epstein-Barr virus viral load in Crohn's disease: effect of immunosuppressive therapy.
|
Inflamm Bowel Dis
|
2004
|
0.94
|
|
30
|
Genotype/phenotype analyses for 53 Crohn's disease associated genetic polymorphisms.
|
PLoS One
|
2012
|
0.93
|
|
31
|
Overexpression of microRNAs-155 and 21 targeting mismatch repair proteins in inflammatory bowel diseases.
|
Carcinogenesis
|
2013
|
0.92
|
|
32
|
Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients.
|
Medicine (Baltimore)
|
2008
|
0.91
|
|
33
|
Gastrointestinal involvement and manifestations in systemic mastocytosis.
|
Inflamm Bowel Dis
|
2010
|
0.90
|
|
34
|
Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2012
|
0.88
|
|
35
|
Erythema nodosum-like eruption as a manifestation of azathioprine hypersensitivity in patients with inflammatory bowel disease.
|
Arch Dermatol
|
2007
|
0.88
|
|
36
|
Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine.
|
Inflamm Bowel Dis
|
2011
|
0.85
|
|
37
|
Gastrointestinal manifestations in mastocytosis: a study of 83 patients.
|
J Allergy Clin Immunol
|
2013
|
0.83
|
|
38
|
The management of immunosuppression in patients with inflammatory bowel disease and cancer.
|
Gut
|
2013
|
0.83
|
|
39
|
Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis.
|
World J Gastroenterol
|
2010
|
0.83
|
|
40
|
Current smoking, not duration of remission, delays Crohn's disease relapse following azathioprine withdrawal.
|
Inflamm Bowel Dis
|
2010
|
0.82
|
|
41
|
Acute cryptosporidiosis as a cause of sudden recurrence of digestive symptoms in patients with Crohn's disease.
|
J Crohns Colitis
|
2010
|
0.81
|
|
42
|
[Undiagnosed celiac disease in childhood].
|
Gastroenterol Clin Biol
|
2002
|
0.81
|
|
43
|
Use of immunosuppressants and biologicals in patients with previous cancer.
|
Dig Dis
|
2013
|
0.81
|
|
44
|
[Intercurrent Klebsiella oxytoca colitis in a patient with Crohn's disease].
|
Gastroenterol Clin Biol
|
2002
|
0.80
|
|
45
|
Human intestinal microbiota gene risk factors for antibiotic-associated diarrhea: perspectives for prevention. Risk factors for antibiotic-associated diarrhea.
|
Microb Ecol
|
2010
|
0.80
|
|
46
|
[Non-digestive complications of inflammatory bowel diseases].
|
Rev Prat
|
2014
|
0.80
|
|
47
|
Risk factors for neoplasia in inflammatory bowel disease patients with pancolitis.
|
Am J Gastroenterol
|
2010
|
0.80
|
|
48
|
Intestinal perforation in Crohn's disease. Factors predictive of surgical resection.
|
Gastroenterol Clin Biol
|
2005
|
0.79
|
|
49
|
Prior appendectomy and the phenotype and course of Crohn's disease.
|
World J Gastroenterol
|
2006
|
0.79
|
|
50
|
Cancers Complicating Inflammatory Bowel Disease.
|
N Engl J Med
|
2015
|
0.79
|
|
51
|
[Recommendations for clinical practice for the treatment of ulcerative colitis].
|
Gastroenterol Clin Biol
|
2004
|
0.77
|
|
52
|
Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular study.
|
Inflamm Bowel Dis
|
2014
|
0.77
|
|
53
|
Single immunoglobulin infusion can reverse hemodynamic failure associated with severe Clostridium difficile colitis.
|
Am J Gastroenterol
|
2009
|
0.77
|
|
54
|
Predictive factors of response of perianal Crohn's disease to azathioprine or 6-mercaptopurine.
|
Dis Colon Rectum
|
2003
|
0.77
|
|
55
|
[IBD and increased risk of cancer: what is the reality?].
|
Rev Infirm
|
2014
|
0.76
|
|
56
|
Risk of melanoma in patients who receive thiopurines for inflammatory bowel disease is not increased.
|
Am J Gastroenterol
|
2012
|
0.76
|
|
57
|
Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy.
|
Inflamm Bowel Dis
|
2016
|
0.76
|
|
58
|
Rotavirus-like particles: a novel nanocarrier for the gut.
|
J Biomed Biotechnol
|
2010
|
0.76
|
|
59
|
Factors associated with durable response to infliximab in Crohn's disease 5 years and beyond: a multicenter international cohort.
|
Inflamm Bowel Dis
|
2015
|
0.76
|
|
60
|
Push enteroscopy for gastrointestinal bleeding: diagnostic yield and long-term follow-up.
|
Gastroenterol Clin Biol
|
2004
|
0.76
|
|
61
|
Patients with drug-induced microscopic colitis should not be included in controlled trials assessing the efficacy of anti-inflammatory drugs in microscopic colitis.
|
Gastroenterology
|
2009
|
0.75
|
|
62
|
Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases.
|
Inflamm Bowel Dis
|
2017
|
0.75
|
|
63
|
Body mass index and disease activity at treatment initiation: potential new predictors of response to azathioprine therapy in IBD.
|
Inflamm Bowel Dis
|
2010
|
0.75
|
|
64
|
Roseolovirus DNA in the colonic mucosa of HIV-seropositive patients with diarrhea.
|
Clin Infect Dis
|
2003
|
0.75
|
|
65
|
[Recommendations for clinical practice for the treatment of ulcerative colitis: general method].
|
Gastroenterol Clin Biol
|
2004
|
0.75
|
|
66
|
[Acute diarrhea in the adult].
|
Rev Prat
|
2010
|
0.75
|
|
67
|
[Practical forms for the use of the main drugs in the treatment of ulcerative colitis].
|
Gastroenterol Clin Biol
|
2004
|
0.75
|
|
68
|
Air mass pushing the liver.
|
Dig Liver Dis
|
2011
|
0.75
|
|
69
|
[Natural history of intestinal lesions in inflammatory bowel disease].
|
Rev Prat
|
2014
|
0.75
|
|
70
|
[Refractory proctitis].
|
Gastroenterol Clin Biol
|
2007
|
0.75
|
|
71
|
[Introduction of the evidence].
|
Gastroenterol Clin Biol
|
2004
|
0.75
|
|
72
|
[New infectious colitis].
|
Gastroenterol Clin Biol
|
2002
|
0.75
|
|
73
|
Thiopurines and myeloid disorders: is more caution needed when treating inflammatory bowel disease patients?
|
Expert Rev Clin Immunol
|
2014
|
0.75
|